X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
index medicus (5) 5
female (4) 4
oncology (4) 4
adult (3) 3
aged (3) 3
antineoplastic agents - therapeutic use (3) 3
cancer (3) 3
disease-free survival (3) 3
drug therapy (3) 3
furans - therapeutic use (3) 3
ketones - therapeutic use (3) 3
middle aged (3) 3
solid tumors (3) 3
analysis (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
breast neoplasms - mortality (2) 2
breast neoplasms - pathology (2) 2
care and treatment (2) 2
drug administration schedule (2) 2
e7389 (2) 2
furans - adverse effects (2) 2
hematology, oncology and palliative medicine (2) 2
ketones - adverse effects (2) 2
male (2) 2
medicine & public health (2) 2
models, biological (2) 2
pharmacology (2) 2
pharmacology & pharmacy (2) 2
pharmacology/toxicology (2) 2
research (2) 2
survival rate (2) 2
vegf (2) 2
abridged index medicus (1) 1
administration, oral (1) 1
aged, 80 and over (1) 1
alpha2-integrin (1) 1
analog (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - pharmacokinetics (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anthracycline (1) 1
antihypertensive agents - administration & dosage (1) 1
antihypertensive agents - therapeutic use (1) 1
antineoplastic agents - pharmacokinetics (1) 1
article (1) 1
bevacizumab (1) 1
biochemistry, general (1) 1
biomedical engineering (1) 1
biomedicine (1) 1
blood pressure - drug effects (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
cancer patients (1) 1
capecitabine (1) 1
chemotherapy (1) 1
complications and side effects (1) 1
diagnosis (1) 1
diagnostic radiology (1) 1
dosage and administration (1) 1
dose-response relationship, drug (1) 1
dynamics (1) 1
e7820 (1) 1
embrace (1) 1
endothelial growth-factor (1) 1
eribulin mesylate (1) 1
europe (1) 1
expression (1) 1
farmaci (1) 1
food (1) 1
furans - administration & dosage (1) 1
guidelines (1) 1
halichondrin b analog (1) 1
halichondrin-b (1) 1
health aspects (1) 1
hypertension (1) 1
hypertension - chemically induced (1) 1
hypertension - drug therapy (1) 1
iii trial (1) 1
imaging / radiology (1) 1
indoles - administration & dosage (1) 1
indoles - pharmacokinetics (1) 1
infusions, intravenous (1) 1
inhibition (1) 1
inhibitor (1) 1
integrin alpha-2 (1) 1
internal medicine (1) 1
interventional radiology (1) 1
ixabepilone plus capecitabine (1) 1
ketones - administration & dosage (1) 1
leiomyosarcoma - drug therapy (1) 1
leiomyosarcoma - pathology (1) 1
mechanism (1) 1
mechanisms (1) 1
medical and health sciences (1) 1
medical research (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 914 - 923
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1045 - 1052
Journal Article
Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, 8/2010, Volume 37, Issue 4, pp. 347 - 363
Hypertension and proteinuria are commonly observed side-effects for anti-angiogenic drugs targeting the VEGF pathway. In most cases, hypertension can be... 
Biochemistry, general | Biomedical Engineering | Hypertension | Pharmacodynamics | Biomedicine | Pharmacy | VEGF | Model | Veterinary Medicine | Pharmacology/Toxicology | Proteinuria | METAANALYSIS | BEVACIZUMAB | RISK | MECHANISMS | TOXICITY | RESPONSES | SUNITINIB | PHARMACOLOGY & PHARMACY | INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | Neoplasms - metabolism | Drug Administration Schedule | Urinalysis | Humans | Antihypertensive Agents - administration & dosage | Phenylurea Compounds - therapeutic use | Hypertension - drug therapy | Angiogenesis Inhibitors - pharmacokinetics | Antihypertensive Agents - therapeutic use | Neoplasms - drug therapy | Proteinuria - prevention & control | Dose-Response Relationship, Drug | Quinolines - pharmacokinetics | Proteinuria - chemically induced | Neoplasms - urine | Models, Biological | Phenylurea Compounds - adverse effects | Hypertension - chemically induced | Angiogenesis Inhibitors - therapeutic use | Blood Pressure - drug effects | Phenylurea Compounds - pharmacokinetics | Quinolines - therapeutic use | Angiogenesis Inhibitors - adverse effects | Quinolines - adverse effects | Tyrosine | Urine | Care and treatment | Antineoplastic agents | Antimitotic agents | Cancer patients | Analysis | Models | Universities and colleges | Drug therapy | Vascular endothelial growth factor | Phosphotransferases | Cancer | Index Medicus | PHARMACY | Medical and Health Sciences | Medicin och hälsovetenskap | FARMACI
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2000, Volume 92, Issue 3, p. 205
  In the late 1970s, the International Union Against Cancer and the World Health Organization introduced specific criteria for the codification of tumor... 
Therapy | Guidelines | Tumors | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.